1.
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
by Matthews, David R
Diabetologia, 2019-06, Vol.62 (6), p.926-938
2.
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
by Heerspink, Hiddo J Lambers, PharmD
The Lancet (British edition), 2009, Vol.373 (9668), p.1009-1015
3.
The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
by Oshima, Megumi
Diabetologia, 2019-07-13, Vol.62 (11), p.1988-1997
4.
Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program
by Zhou, Zien
Diabetologia, 2019-10, Vol.62 (10), p.1854-1867
5.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
by Sundström, Johan
The Lancet (British edition), 2014-08-16, Vol.384 (9943), p.591-598
Filter electronic articles 5 Hits
Remove Filters
- Cardiovascular Diseases
- Risk Factors (4)
- Human Physiology (3)
- Humans (3)
- Medicine (3)
- Medicine & Public Health (3)
- Metabolic Diseases (3)
- Health Aspects (3)
- Endocrinology & Metabolism (3)
- Cardiovascular Disease (3)
- Diabetes (3)
- Diabetes Mellitus (3)
- Base-Line Characteristics (2)
- Antihypertensive Agents - Therap... (2)
- 1103 Clinical Sciences (2)
- 1114 Paediatrics (2)
- 1117 Public Health (2)
- less ...